Elicio Therapeutics ($ELTX) Insider Trading & Smart Money Activity

Elicio Therapeutics, Inc. · Biotechnology · Latest filing Jun 18, 2026

Elicio Therapeutics, Inc. ($ELTX) has 4 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

4

ELTX insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ELTX insider, congress, 13F and analyst activity

All Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 18, 2026	Analyst	Ladenburg Thalmann	Raises to buy		PT $12		-2.6%	-21.0%			Read
Jun 15, 2026	Analyst	HC Wainwright	Reiterates to buy		PT $23		+1.5%	-25.5%			Read
Jun 10, 2026	Analyst	B. Riley Securities	Reiterates to buy		PT $27		-67.1%	-75.7%			—
Jun 10, 2026	Analyst	B. Riley Securities	Reiterates to buy		PT $27		-67.1%	-75.7%			Read

1W / 1M / 6M = how ELTX moved from the trade or filing date.

Analyst ratings on ELTX

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 18, 2026	Ladenburg Thalmann	Raises	buy	$12	-2.6%	-21.0%		Read
Jun 15, 2026	HC Wainwright	Reiterates	buy	$23	+1.5%	-25.5%		Read
Jun 10, 2026	B. Riley Securities	Reiterates	buy	$27	-67.1%	-75.7%		—
Jun 10, 2026	B. Riley Securities	Reiterates	buy	$27	-67.1%	-75.7%		Read

Other biotechnology stocks

• $HRTX
• $INKT
• $TIL
• $HOWL
• $LITS
• $CALC
• $SER
• $XLO

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.